Cargando…

Acute infection as a trigger for incident venous thromboembolism: Results from a population‐based case‐crossover study

ESSENTIALS: There is a bidirectional relation between acute infections and immobilization. We studied the impact of infection and immobilization on risk of VTE in a case‐crossover design. Acute infection was a strong trigger for VTE independent of concomitant immobilization. Infection and immobiliza...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grimnes, Gro, Isaksen, Trond, Tichelaar, Y. I. G. Vladimir, Brækkan, Sigrid K., Hansen, John‐Bjarne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles: Thrombosis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055491/ https://www.ncbi.nlm.nih.gov/pubmed/30046710 http://dx.doi.org/10.1002/rth2.12065

Ejemplares similares

C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study
por: Grimnes, Gro, et al.
Publicado: (2018)

The Role of Stroke as a Trigger for Incident Venous Thromboembolism: Results from a Population-based Case-Crossover Study
por: Morelli, Vânia M., et al.
Publicado: (2019)

Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism
por: Frischmuth, Tobias, et al.
Publicado: (2022)

Dietary intake of marine n‐3 polyunsaturated fatty acids and future risk of venous thromboembolism
por: Isaksen, Trond, et al.
Publicado: (2018)

Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism—the Tromsø study
por: Børvik, Trond, et al.
Publicado: (2020)

Surgery As a Trigger for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study
por: Meknas, Dana, et al.
Publicado: (2023)

Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2022)

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
por: Hald, Erin Mathiesen, et al.
Publicado: (2020)

The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer
por: Ellingsen, Trygve S., et al.
Publicado: (2018)

Cancer‐associated venous thromboembolism: Incidence and features in a racially diverse population
por: Raskob, Gary E., et al.
Publicado: (2022)

Genetic risk and incident venous thromboembolism in middle‐aged and older adults following COVID‐19 vaccination
por: Xie, Junqing, et al.
Publicado: (2022)

Overall and abdominal obesity in relation to venous thromboembolism
por: Yuan, Shuai, et al.
Publicado: (2020)

Hematocrit and incidence of venous thromboembolism
por: Folsom, Aaron R., et al.
Publicado: (2020)

Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta‐analysis
por: Mulder, Frits I., et al.
Publicado: (2020)

Role of microRNAs in Venous Thromboembolism
por: Morelli, Vânia M., et al.
Publicado: (2020)

Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2020)

Evaluation of the Khorana, PROTECHT, and 5‐SNP scores for prediction of venous thromboembolism in patients with cancer
por: Guman, Noori A. M., et al.
Publicado: (2021)

Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study
por: Crobach, Monique J. T., et al.
Publicado: (2023)

Resting heart rate and incidence of venous thromboembolism
por: Folsom, Aaron R., et al.
Publicado: (2019)

Clinical characteristics and outcomes of incidental venous thromboembolism in cancer patients: Insights from the Caravaggio study
por: Giustozzi, Michela, et al.
Publicado: (2021)

D‐dimer to rule out venous thromboembolism during pregnancy: A systematic review and meta‐analysis
por: Bellesini, Marta, et al.
Publicado: (2021)

Pharmacokinetic modeling and simulation support for age‐ and weight‐adjusted dosing of dabigatran etexilate in children with venous thromboembolism
por: Röshammar, Daniel, et al.
Publicado: (2021)

Risk of recurrence in women with venous thromboembolism related to estrogen‐containing contraceptives: Systematic review and meta‐analysis
por: Wiegers, Hanke M. G., et al.
Publicado: (2022)

Weight Change and Risk of Venous Thromboembolism: The Tromsø Study
por: Horvei, Lars Daae, et al.
Publicado: (2016)

Hand grip strength and risk of incident venous thromboembolism: The Tromsø study
por: Leknessund, Oda G. R., et al.
Publicado: (2022)

Dynamic assessment of venous thromboembolism risk in patients with cancer by longitudinal D‐Dimer analysis: A prospective study
por: Posch, Florian, et al.
Publicado: (2020)

Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for World Thrombosis Day
por: Potere, Nicola, et al.
Publicado: (2022)

Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta‐analysis
por: Horner, Daniel, et al.
Publicado: (2019)

Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up
por: Salisbury, Richard, et al.
Publicado: (2020)

Risk of a permanent work-related disability pension after incident venous thromboembolism in Denmark: A population-based cohort study
por: Jørgensen, Helle, et al.
Publicado: (2021)

Galectin‐3 and venous thromboembolism incidence: the Atherosclerosis Risk in Communities (ARIC) Study
por: Fashanu, Oluwaseun E., et al.
Publicado: (2017)

Hand grip strength in venous thromboembolism: risk of recurrence and mortality
por: Leknessund, Oda G.R., et al.
Publicado: (2023)

Evidence-base for aspirin as venous thromboembolic prophylaxis following joint replacement
por: Jameson, S. S., et al.
Publicado: (2014)

Achieving higher efficacy without compromising safety with factor XI inhibitors versus low molecular weight heparin for the prevention of venous thromboembolism in major orthopedic surgery—Systematic review and meta‐analysis
por: Presume, João, et al.
Publicado: (2022)

Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study
por: Hill, Jason B., et al.
Publicado: (2020)

Polygenic risk of major depressive disorder as a risk factor for venous thromboembolism
por: Ward, Joey, et al.
Publicado: (2023)

Inherited Thrombophilias Are Associated with an Increased Risk of COVID-19 Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study
por: Stevens, Hannah P, et al.
Publicado: (2021)

Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review
por: Tøndel, Birgitte G., et al.
Publicado: (2022)

Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
por: Wells, Philip S., et al.
Publicado: (2022)

Immigration, region of origin, and the epidemiology of venous thromboembolism: A population‐based study
por: Lazo‐Langner, Alejandro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m30a8feqkn5oja9pfmrcdos5f7